Author: Dr. Uma Pillai and Upasana Meghwal
Affiliation: Dr. Uma Pillai (Supervisor) and Upasana Meghwal (Scholar), Lachoo Memorial College of Science and Technology, Jodhpur
Volume/Issue: Vol. 1 (Jan–June 2026)
Pages: 69–74
Abstract
Intravenous (IV) drug therapy remains a critical component of contemporary healthcare because of its rapid therapeutic action, complete bioavailability, and suitability for critically ill patients. In India, significant reforms in intravenous medication management have emerged in response to growing concerns regarding patient safety, medication errors, antimicrobial resistance, healthcare-associated infections, and increasing treatment complexity. The modernization of healthcare systems, adoption of evidence-based clinical practices, implementation of accreditation standards, and expansion of digital technologies have transformed intravenous drug administration across diverse healthcare settings. Modern strategies include standardized infusion protocols, antimicrobial stewardship initiatives, centralized intravenous admixture services, smart infusion technologies, electronic medication management systems, and multidisciplinary patient care models. These reforms have improved medication safety, therapeutic effectiveness, and healthcare quality while supporting rational drug use. However, challenges related to infrastructure, workforce shortages, regional disparities, and financial limitations continue to affect implementation. This article critically examines the evolution, significance, and future prospects of intravenous drug reforms within the Indian healthcare system and explores their contribution to modern medical strategies.
Keywords: Intravenous Therapy, Medication Safety, Healthcare Reform, Antimicrobial Stewardship, Patient Safety, India, Infusion Management.